RIVERSIDE, CA--(Marketwire - June 12, 2012) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with proprietary products for the growing respiratory markets announced today that major home healthcare providers and oxygen service providers have made substantial product orders and will debut the Oxyview® product line on their websites while they are seeking to capitalize on the booming aging population and the increase in home healthcare services. Since the introduction of the new Smart Nasal Cannula® in 2010, Ingen's Oxyview® product line continues to fill a void for the 32 million home oxygen patients in the United States, and 600 million patients worldwide. The company has sold more than 100,000 units to patients so far through a variety of suppliers, hospitals and COPD (Chronic Obstructive Pulmonary Disease) organizations during the past few years.
Some of these suppliers are Tonopah Medical, LLC in Las Vegas; Mountainside Medical Equipment Company in New York; and OxiMedical Respiratory in Arizona.
Chairman Gary Tilden stated, "Tonopah Medical has been a very consistent client who recently purchased another 500 units for their home oxygen patients throughout the Las Vegas area, as well as Mountainside Medical in New York who made a recent purchase of 200 units. As the company expands the distribution and marketing programs we hope to see an increase in revenues and earnings. Our Oxyview® product line offers many benefits to the patients and cost advantages to oxygen providers and suppliers."
FOR MORE UPDATED INFORMATION USE THE FOLLOWING LINK: WWW.OTCFN.COM/IGNT
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.